Lignapharma SRL
The score of Lignapharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity 0 % Total assets +6 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Lignapharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 62,682 € | ||||
| Equity | 36,300 € | ||||
| Cash | 121,722 € | ||||
| EBITDA | 100,782 € | ||||
| Total assets | 249,939 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 17 Dec 2025
- Year ended 30 Jun 2024filed on 16 Dec 2024
- Year ended 30 Jun 2023filed on 21 Dec 2023
- Year ended 30 Jun 2022filed on 21 Dec 2022
- Year ended 30 Jun 2021filed on 23 Dec 2021
Lignapharma's financial analysis
- Solvency14.5%sector median: 35.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Lignapharma
Lignapharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0840.469.861
- VAT number
- BE0840469861
- Peppol
- Registered · 0208:0840469861 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Oct 2011
- Registered office
- 2400 Mol
- Latest accounts
- 2025 · filed on 17 Dec 2025
- Activity
- Activities of agents involved in the wholesale of food, beverages and tobacco (NACE 46170)
Lignapharma (SRL) has been based in Mol since 2011, active in: activities of agents involved in the wholesale of food, beverages and tobacco. For 2025, it reports a net profit of 62,682 € and equity of 36,300 €; its revenue is not published. Its solvency stands at 14.5%, below the median of its sector (35.8%).
Companies similar to Lignapharma
Companies in the same business, of comparable size and area, outside its group.
- Quality Sourcing Solutions Wholesale of other food Ghent · balance sheet €2.20m
- DL4 Activities of agents involved in the wholesale of food, beverages and tobacco Aiseau-Presles · balance sheet 245,107 €
- Eleadora Wholesale of other food Haaltert · balance sheet 246,236 €
- V-Cubes BY Veggiebel Manufacture of other food products n.e.c. Ypres · balance sheet 210,727 €
- Condilux Activities of agents involved in the wholesale of food, beverages and tobacco Virton · balance sheet 148,239 €
- Amalie Activities of agents involved in the wholesale of food, beverages and tobacco Wielsbeke · balance sheet 217,700 €
- Euphoria Activities of agents involved in the wholesale of food, beverages and tobacco Ninove · balance sheet 341,905 €
- SA&AR Activities of agents involved in the wholesale of food, beverages and tobacco Bruges · balance sheet 167,501 €
Frequently asked questions about Lignapharma
What is the revenue of Lignapharma?
Lignapharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Lignapharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0840469861 for Lignapharma, if the company is VAT-registered. Its company number (CBE) is 0840.469.861.
Where is the registered office of Lignapharma?
According to the CBE register, the registered office of Lignapharma is in 2400 Mol.
What is the equity of Lignapharma?
At the close of the 2025 financial year, the equity of Lignapharma amounts to 36,300 €, a solvency of 14.5% of total assets.
Who manages Lignapharma?
The register lists 2 active mandates at Lignapharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Lignapharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →